OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy
Abigail Colley, Timothy Brauns, Ann E. Sluder, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 765-780
Closed Access | Times Cited: 5
Abigail Colley, Timothy Brauns, Ann E. Sluder, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 765-780
Closed Access | Times Cited: 5
Showing 5 citing articles:
Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance
Xiaolin Wu, Nuan Feng, Chao Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Xiaolin Wu, Nuan Feng, Chao Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Thalidomide can effectively prevent relapse in IgG4-related disease outweighing its side effects: a multicentre, randomised, double-blinded, placebo-controlled study
Yu Chen, Cong Ye, Pingting Yang, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Yu Chen, Cong Ye, Pingting Yang, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Targeted degradation of GOLM1 by CC-885 via CRL4-CRBN E3 ligase inhibits hepatocellular carcinoma progression
Jingliang He, Jingli Guo, Shunfang Liu, et al.
Cellular Signalling (2025), pp. 111665-111665
Closed Access
Jingliang He, Jingli Guo, Shunfang Liu, et al.
Cellular Signalling (2025), pp. 111665-111665
Closed Access
Simultaneous determination of thirteen related substances in lenalidomide API by a stability-indicating RP-HPLC method
Zhiling Cao, MikeâQingtao Huang, Liu Bi, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116823-116823
Closed Access
Zhiling Cao, MikeâQingtao Huang, Liu Bi, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116823-116823
Closed Access
Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy
Xiaoyan Qi, Cheng Cheng, Dawei Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Xiaoyan Qi, Cheng Cheng, Dawei Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
